Antibacterial |
A drug that kills or
inhibits the growth of bacteria. |
Antibiotics |
A class of substances
that kill or inhibit the growth of bacteria. Examples are
penicillin, tetracycline, and fluoroquinolones. Originally,
antibiotics were derived from natural sources, e.g., penicillin
from molds, but many currently used antibiotics are semi-synthetic
and modified with additions of synthetic chemical components.
Some scientists reserve the term antibiotic for naturally
produced substances and use antimicrobial to encompass both
synthetic and natural forms. |
Antibiotic
resistance |
The capacity of bacteria
to inactivate or exclude antibiotics or otherwise block their
inhibitory or killing effects. Resistant bacteria evolve as
a result of using antibiotics. Antibiotics kill or inhibit
susceptible bacteria and resistant ones survive. |
Antibiotic
susceptibility |
The opposite of resistance
and applies to bacteria that are killed or inhibited by an
antibiotic. Susceptibility to one antibiotic does not mean
susceptibility to all antibiotics. |
Antimicrobials |
A class of substances
that destroy or inhibit the growth of bacteria. Includes synthetic
and natural chemical substances. |
Bacteria |
Microscopic, single-celled
organisms. |
Broad-spectrum
antibiotic |
An antibiotic effective
against a large number of bacterial species. |
Commensal bacteria |
Bacteria that live
inside or on the body and do not usually cause disease. May
be beneficial to the host. |
Escherichia
coli |
commensal bacteria
that live in the intestine and sometimes causes opportunistic
infections. |
Flora |
The populations of
commensal bacteria normally present in the intestine, body
openings, and on the skin. |
Food-borne
pathogens |
Food-borne pathogens
are defined as infectious organisms associated with livestock
which can cause diseases in humans. They include Salmonella,
Campylobacter, E. coli O157:H7, and Listeria. |
Gene |
A segment of DNA that
carries the directions for the structure of a given protein.
Antibiotic-resistance genes direct the synthesis of antibiotic-resistance
proteins. |
Incidence |
The frequency of new
occurrences of disease within a defined time interval. Incidence
rate is the number of new cases of a specified disease divided
by the number of people in a population over a specified period
of time, usually one year. |
Methicillin-resistant
Staphylococcus aureus (MRSA) |
Strictly speaking,
a bacterial strain resistant to methicillin. In practice,
MRSAs are generally resistant to many antibiotics and some
are resistant to all but vancomycin. |
Microorganism |
Minute, microscopic
or submicroscopic living organisms; includes bacteria, fungi,
and protozoa. Viruses are often included in this category
though they are incapable of growth and reproduction outside
of host cells. |
Multiple drug
resistance |
Applies to bacteria
that are resistant to more than one antibiotic. |
Narrow spectrum
antibiotic |
An antibiotic effective
against a limited number of microorganisms. |
Nosocomial
infection |
Infection acquired
during hospitalization that is not present at the time of
hospital admission. |
Opportunistic
infection |
An infection caused
by an organism that is usually benign, such as a commensal
bacterium. |
Pathogen |
An organism that is capable
of causing disease. |
Pathogenicity |
Capacity to cause disease. |
Prophylactic
use of antibiotics |
Treating with antibiotics
before evidence of infection to prevent disease. In livestock
production, prophylactic doses may range from sub therapeutic
to therapeutic levels depending upon the drug, the animal,
and environment. |
Therapeutic
uses of antibiotics |
Treating with antibiotics
once a disease has developed |